SIGIRR/TIR-8 is an inhibitor of Toll-like receptor signaling in primary human cells and regulates inflammation in models of rheumatoid arthritis.

OBJECTIVE: Single-immunoglobulin interleukin-1 receptor-related (SIGIRR), which is also known as Toll/interleukin-1 receptor 8 (TIR-8), is a member of the TIR domain-containing family of receptors and was first characterized as an inhibitor of interleukin-1 receptor (IL-1R) and Toll-like receptor (...

Full description

Bibliographic Details
Main Authors: Drexler, S, Kong, P, Inglis, J, Williams, R, Garlanda, C, Mantovani, A, Yazdi, A, Brennan, F, Feldmann, M, Foxwell, B
Format: Journal article
Language:English
Published: 2010
_version_ 1797062554462191616
author Drexler, S
Kong, P
Inglis, J
Williams, R
Garlanda, C
Mantovani, A
Yazdi, A
Brennan, F
Feldmann, M
Foxwell, B
author_facet Drexler, S
Kong, P
Inglis, J
Williams, R
Garlanda, C
Mantovani, A
Yazdi, A
Brennan, F
Feldmann, M
Foxwell, B
author_sort Drexler, S
collection OXFORD
description OBJECTIVE: Single-immunoglobulin interleukin-1 receptor-related (SIGIRR), which is also known as Toll/interleukin-1 receptor 8 (TIR-8), is a member of the TIR domain-containing family of receptors and was first characterized as an inhibitor of interleukin-1 receptor (IL-1R) and Toll-like receptor (TLR) signaling. In the Dextran sulfate sodium-induced colitis model, SIGIRR(-/-) mice were shown to have increased inflammation and to be more susceptible to endotoxin challenge. Increasing evidence implicates TLR and IL-1R signaling in the pathology of rheumatoid arthritis (RA). Therefore, the purpose of this study was to investigate the involvement of SIGIRR in regulating inflammation in disease-relevant models. METHODS: Primary human monocyte-derived macrophages and dendritic cells (DCs) were used to overexpress SIGIRR as well as to knock down endogenously expressed SIGIRR using small interfering RNAs. SIGIRR was also overexpressed in synovial cells derived from RA patients. To investigate the role of SIGIRR in vivo, zymosan-induced arthritis (ZIA) and collagen antibody-induced arthritis (CAIA) were induced in SIGIRR-knockout mice. RESULTS: SIGIRR overexpression inhibited TLR-induced cytokine production in macrophages and DCs, while SIGIRR knockdown resulted in increased cytokine production following TLR stimulation. Moreover, SIGIRR overexpression inhibited the spontaneous release of cytokines by human RA synovial cells. The role of SIGIRR as an inhibitor of inflammation was confirmed in vivo, since SIGIRR(-/-) mice developed a more severe disease in both the ZIA and CAIA models. CONCLUSION: Our study is the first to show the expression pattern and function of SIGIRR in primary human cells. Furthermore, this investigation defines the role of SIGIRR in disease-relevant cell types and demonstrates that SIGIRR is a potential therapeutic target for RA.
first_indexed 2024-03-06T20:47:10Z
format Journal article
id oxford-uuid:364c9d1f-3a3d-4d6d-8aa0-fffcd1f70386
institution University of Oxford
language English
last_indexed 2024-03-06T20:47:10Z
publishDate 2010
record_format dspace
spelling oxford-uuid:364c9d1f-3a3d-4d6d-8aa0-fffcd1f703862022-03-26T13:37:02ZSIGIRR/TIR-8 is an inhibitor of Toll-like receptor signaling in primary human cells and regulates inflammation in models of rheumatoid arthritis.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:364c9d1f-3a3d-4d6d-8aa0-fffcd1f70386EnglishSymplectic Elements at Oxford2010Drexler, SKong, PInglis, JWilliams, RGarlanda, CMantovani, AYazdi, ABrennan, FFeldmann, MFoxwell, B OBJECTIVE: Single-immunoglobulin interleukin-1 receptor-related (SIGIRR), which is also known as Toll/interleukin-1 receptor 8 (TIR-8), is a member of the TIR domain-containing family of receptors and was first characterized as an inhibitor of interleukin-1 receptor (IL-1R) and Toll-like receptor (TLR) signaling. In the Dextran sulfate sodium-induced colitis model, SIGIRR(-/-) mice were shown to have increased inflammation and to be more susceptible to endotoxin challenge. Increasing evidence implicates TLR and IL-1R signaling in the pathology of rheumatoid arthritis (RA). Therefore, the purpose of this study was to investigate the involvement of SIGIRR in regulating inflammation in disease-relevant models. METHODS: Primary human monocyte-derived macrophages and dendritic cells (DCs) were used to overexpress SIGIRR as well as to knock down endogenously expressed SIGIRR using small interfering RNAs. SIGIRR was also overexpressed in synovial cells derived from RA patients. To investigate the role of SIGIRR in vivo, zymosan-induced arthritis (ZIA) and collagen antibody-induced arthritis (CAIA) were induced in SIGIRR-knockout mice. RESULTS: SIGIRR overexpression inhibited TLR-induced cytokine production in macrophages and DCs, while SIGIRR knockdown resulted in increased cytokine production following TLR stimulation. Moreover, SIGIRR overexpression inhibited the spontaneous release of cytokines by human RA synovial cells. The role of SIGIRR as an inhibitor of inflammation was confirmed in vivo, since SIGIRR(-/-) mice developed a more severe disease in both the ZIA and CAIA models. CONCLUSION: Our study is the first to show the expression pattern and function of SIGIRR in primary human cells. Furthermore, this investigation defines the role of SIGIRR in disease-relevant cell types and demonstrates that SIGIRR is a potential therapeutic target for RA.
spellingShingle Drexler, S
Kong, P
Inglis, J
Williams, R
Garlanda, C
Mantovani, A
Yazdi, A
Brennan, F
Feldmann, M
Foxwell, B
SIGIRR/TIR-8 is an inhibitor of Toll-like receptor signaling in primary human cells and regulates inflammation in models of rheumatoid arthritis.
title SIGIRR/TIR-8 is an inhibitor of Toll-like receptor signaling in primary human cells and regulates inflammation in models of rheumatoid arthritis.
title_full SIGIRR/TIR-8 is an inhibitor of Toll-like receptor signaling in primary human cells and regulates inflammation in models of rheumatoid arthritis.
title_fullStr SIGIRR/TIR-8 is an inhibitor of Toll-like receptor signaling in primary human cells and regulates inflammation in models of rheumatoid arthritis.
title_full_unstemmed SIGIRR/TIR-8 is an inhibitor of Toll-like receptor signaling in primary human cells and regulates inflammation in models of rheumatoid arthritis.
title_short SIGIRR/TIR-8 is an inhibitor of Toll-like receptor signaling in primary human cells and regulates inflammation in models of rheumatoid arthritis.
title_sort sigirr tir 8 is an inhibitor of toll like receptor signaling in primary human cells and regulates inflammation in models of rheumatoid arthritis
work_keys_str_mv AT drexlers sigirrtir8isaninhibitoroftolllikereceptorsignalinginprimaryhumancellsandregulatesinflammationinmodelsofrheumatoidarthritis
AT kongp sigirrtir8isaninhibitoroftolllikereceptorsignalinginprimaryhumancellsandregulatesinflammationinmodelsofrheumatoidarthritis
AT inglisj sigirrtir8isaninhibitoroftolllikereceptorsignalinginprimaryhumancellsandregulatesinflammationinmodelsofrheumatoidarthritis
AT williamsr sigirrtir8isaninhibitoroftolllikereceptorsignalinginprimaryhumancellsandregulatesinflammationinmodelsofrheumatoidarthritis
AT garlandac sigirrtir8isaninhibitoroftolllikereceptorsignalinginprimaryhumancellsandregulatesinflammationinmodelsofrheumatoidarthritis
AT mantovania sigirrtir8isaninhibitoroftolllikereceptorsignalinginprimaryhumancellsandregulatesinflammationinmodelsofrheumatoidarthritis
AT yazdia sigirrtir8isaninhibitoroftolllikereceptorsignalinginprimaryhumancellsandregulatesinflammationinmodelsofrheumatoidarthritis
AT brennanf sigirrtir8isaninhibitoroftolllikereceptorsignalinginprimaryhumancellsandregulatesinflammationinmodelsofrheumatoidarthritis
AT feldmannm sigirrtir8isaninhibitoroftolllikereceptorsignalinginprimaryhumancellsandregulatesinflammationinmodelsofrheumatoidarthritis
AT foxwellb sigirrtir8isaninhibitoroftolllikereceptorsignalinginprimaryhumancellsandregulatesinflammationinmodelsofrheumatoidarthritis